{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:08:09Z","timestamp":1782756489791,"version":"3.54.5"},"reference-count":92,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012329","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T07:00:07Z","timestamp":1472799607000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oxycodone for pain in fibromyalgia in adults"],"prefix":"10.1002","volume":"2016","author":[{"given":"Helen","family":"Gaskell","sequence":"first","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Stannard","sequence":"additional","affiliation":[{"name":"Frenchay Hospital; Pain Clinic, Macmillan Centre; Bristol UK BS16 1LE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD012329-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1185\/03007995.2014.946126","article-title":"Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet","volume":"30","author":"Lux","year":"2014","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD012329-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.37842","article-title":"The fibromyalgia family study: a genome-wide linkage scan study","volume":"65","author":"Arnold","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012329-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1136\/bmj.i20","article-title":"WHO analgesic ladder: a good concept gone astray","volume":"352","author":"Ballantyne","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012329-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012329-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122 (12 Suppl)","author":"Bradley","year":"2009","journal-title":"American Journal of Medicine"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012329-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.amjmed.2012.12.001","article-title":"The effect of opioid therapy on endocrine function","volume":"126","author":"Brennan","year":"2013","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012329-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jpain.2012.08.008","article-title":"Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment","volume":"14","author":"Butler","year":"2013","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012329-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jpain.2010.01.267","article-title":"The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study","volume":"11","author":"Choi","year":"2010","journal-title":"Journal of Pain"},{"issue":"15","key":"10.1002\/14651858.CD012329-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD012329-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1503\/cmaj.090784","article-title":"Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone","volume":"181","author":"Dhalla","year":"2009","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00482-012-1167-z","article-title":"Fibromyalgia syndrome. General principles and coordination of clinical care and patient education","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012329-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"898493","DOI":"10.1155\/2013\/898493","article-title":"Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study","volume":"2013","author":"Fitzcharles","year":"2013","journal-title":"Pain Research and Treatment"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Research and Management"},{"issue":"11","key":"10.1002\/14651858.CD012329-BIB0015|cit15","first-page":"2458","article-title":"Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study","volume":"26","author":"Forseth","year":"1999","journal-title":"Journal of Rheumatology"},{"issue":"14","key":"10.1002\/14651858.CD012329-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","article-title":"Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology","volume":"83","author":"Franklin","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002763.pub2","article-title":"Single dose oral oxycodone and oxycodone plus paracetamol (acetaminophen) for acute postoperative pain in adults","author":"Gaskell","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012329-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub3","article-title":"Oxycodone for neuropathic pain in adults","author":"Gaskell","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012329-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.mayocp.2016.02.002","article-title":"Opioid use in fibromyalgia: a cautionary tale","volume":"91","author":"Goldenberg","year":"2016","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD012329-BIB0020|cit20","unstructured":"McMaster University (developed by Evidence Prime, Inc.) GRADEpro Guideline Development Tool 2016"},{"issue":"12","key":"10.1002\/14651858.CD012329-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence \u00ad inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012329-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12364","article-title":"Evaluating guideline-recommended pain medication use among patients with newly diagnosed fibromyalgia","volume":"Oct 7","author":"Halpern","year":"2015","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD012329-BIB0025|cit25","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012329-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD012329-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2474-13-74","article-title":"The German fibromyalgia consumer reports - a cross-sectional survey","volume":"13","author":"H\u00e4user","year":"2012","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"8","key":"10.1002\/14651858.CD012329-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012329-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","article-title":"Fibromyalgia syndrome - a somatoform disorder?","volume":"18","author":"H\u00e4user","year":"2014","journal-title":"European Journal of Pain"},{"issue":"43","key":"10.1002\/14651858.CD012329-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3238\/arztebl.2014.0732","article-title":"Long-term opioid use in non-cancer pain","volume":"111","author":"H\u00e4user","year":"2014","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1002\/14651858.CD012329-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"Article number:","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00482-014-1452-0","article-title":"Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks","volume":"29","author":"H\u00e4user","year":"2015","journal-title":"Schmerz"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pain.2007.09.027","article-title":"How different is oxycodone from morphine?","volume":"132","author":"Kalso","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5055\/jom.2013.0160","article-title":"Rationale and design of the Oxycodone Users Registry: a prospective, multicenter registry of patients with nonmalignant pain","volume":"9","author":"Kim","year":"2013","journal-title":"Journal of Opioid Management"},{"key":"10.1002\/14651858.CD012329-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain - differences and similarities: a comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012329-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12325-010-0036-3","article-title":"Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain","volume":"27","author":"Lange","year":"2010","journal-title":"Advances in Therapy"},{"issue":"4","key":"10.1002\/14651858.CD012329-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: a systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatology International"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/bja\/aet351","article-title":"Chronic widespread pain, including fibromyalgia: a pathway for care developed by the British Pain Society","volume":"112","author":"Lee","year":"2014","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012329-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","author":"Macfarlane","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","article-title":"A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population","volume":"157","author":"Mansfield","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012329-BIB0046|cit46","volume-title":"An Evidence-Based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"4(pt 1)","key":"10.1002\/14651858.CD012329-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.lpm.2016.02.014","article-title":"Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain","volume":"45","author":"Moisset","year":"2016","journal-title":"Presse M\u00e9dicale"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012329-BIB0049|cit49","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pain.2010.02.032","article-title":"Chronic low back pain analgesic studies - a methodological minefield","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012329-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012329-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD012329-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012329-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012329-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD012329-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD012329-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/acr.20118","article-title":"Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Tr\u00f8ndelag Health Study","volume":"62","author":"Mork","year":"2010","journal-title":"Arthritis Care & Research"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012329-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012329-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/ACO.0b013e32832bc818","article-title":"Oxycodone: new 'old' drug","volume":"22","author":"Olkkola","year":"2009","journal-title":"Current Opinion in Anesthesiology"},{"issue":"4","key":"10.1002\/14651858.CD012329-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.tips.2013.02.001","article-title":"Does the pharmacology of oxycodone justify its increasing use as an analgesic?","volume":"34","author":"Olkkola","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1002\/14651858.CD012329-BIB0070|cit70","unstructured":"Cochrane Pain, Palliative and Supportive Care Group (PaPaS) author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"1","key":"10.1002\/14651858.CD012329-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AJP.0000000000000079","article-title":"Long-term evaluation of opioid treatment in fibromyalgia","volume":"31","author":"Peng","year":"2015","journal-title":"Clinical Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0885-3924(93)90101-Z","article-title":"A review of oxycodone's clinical pharmacokinetics and pharmacodynamics","volume":"8","author":"P\u00f6yhi\u00e4","year":"1993","journal-title":"Journal of Pain & Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD012329-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD012329-BIB0074|cit74","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003870.pub5","article-title":"Oxycodone for cancer-related pain","author":"Schmidt-Hansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012329-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00482-012-1174-0","article-title":"Etiology and pathophysiology of fibromyalgia syndrome","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD012329-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012329-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012329-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2474-12-125","article-title":"Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response","volume":"12","author":"Straube","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012329-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"9859","key":"10.1002\/14651858.CD012329-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD012329-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"e0138024","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1002\/14651858.CD012329-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012329-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012329-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012329-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD012329-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"645","author":"Wolfe","year":"2013","journal-title":"Arthritis Care and Research"},{"issue":"7","key":"10.1002\/14651858.CD012329-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012329-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD012329-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1002\/14651858.CD012329-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010782","article-title":"Anticonvulsants for fibromyalgia","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012329-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub2","article-title":"Oxycodone for neuropathic pain and fibromyalgia in adults","author":"Gaskell","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T01:04:52Z","timestamp":1634778292000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012329"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":92,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012329","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]}}}